Sleep Cycle Stock Price

SLEEP Community Fair Values

• AN

  

  AnalystConsensusTarget

  Consensus Narrative from 3 Analysts

  Expanding Technology And Sleep Apnea Initiatives Will Open New Opportunities

  Key Takeaways Strategic partnerships and technology licensing initiatives may diversify revenue streams and improve margins by leveraging Sleep Cycle's technology in various industries. Entry into the sleep apnea market and ongoing medical certifications could address significant unmet needs, potentially boosting revenue and earnings.

  SEK 38.50

  FV

  21.2% undervalued intrinsic discount

  13.97%

  Revenue growth p.a.

  0users have liked this narrative

  0users have commented on this narrative

  10users have followed this narrative

  5 days ago author updated this narrative
• BO

  Bonywall

  Community Contributor

  Can Sleep Cycle Protect Its Competitive Edge Amid Market Challenges?

  Sleep Cycle AB — Investment Narrative, Update Q1 2025 Executive Summary Sleep Cycle AB (Nasdaq Stockholm: SLEEP) is the category-leading sleep-tracking app with ~904 000 paying subscribers and a decade-long proprietary data set exceeding three billion recorded nights. The asset-light subscription model generates robust profitability (average EBIT margin ≈ 26 % over 2022-2024) while free cash flow and a net-cash balance (≈ 157 m) support an ordinary plus special dividend.

  SEK 46.03

  FV

  34.1% undervalued intrinsic discount

  8.00%

  Revenue growth p.a.

  0users have liked this narrative

  0users have commented on this narrative

  1users have followed this narrative

  3 months ago author updated this narrative
• MA

  Mandelman

  Community Contributor

  Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model

  Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.

  SEK 51.80

  FV

  41.4% undervalued intrinsic discount

  10.00%

  Revenue growth p.a.

  1users have liked this narrative

  0users have commented on this narrative

  19users have followed this narrative

  3 months ago author updated this narrative